Peter Hillmen, Joris Diels, Nollaig Healy, Wafae Iraqi, Johan Aschan, Mark Wildgust. Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program. haematol [Internet]. 2018Apr.30 [cited 2024Apr.24];103(5):e204-e206. Available from: https://haematologica.org/article/view/8468